Professor Arthur Christopoulos named Australia’s top researcher in pharmacology & pharmacy

Professor Arthur Christopoulos

11 November 2021

Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, Professor Arthur Christopoulos, has been named the top researcher in the field of pharmacology and pharmacy in The Australian’s 2021 Research magazine.

Each year the magazine's higher education team reports the top researchers in their field based on the number of citations for papers published in the top 20 journals in each field over the past five years.

Professor Christopoulos has been named a top researcher within Health and Medical Sciences, and Monash University has been named the top research institute in the field of pharmacy and pharmacology.

Professor Christopoulos is world-renowned for his pioneering discoveries of spatially distinct ‘allosteric’ drug binding sites on G protein-coupled receptors (GPCRs), the largest class of all medicinal targets. His innovative research crosses academic and industry boundaries, incorporating computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and models of behaviour and disease.

Despite the challenges of 2021, it’s been a year of achievements for Professor Christopoulos. Notable highlights include:

  • In May his contribution to the scientific community was recognised at the highest level when he was elected a Fellow of the Australian Academy of Science (FAA) for his ground-breaking research, both within Australia and globally. Fellows of the Australian Academy of Science are among the nation’s most distinguished scientists, nominated by their peers for work that has made a clear impact.
  • He co-led a study published in Nature on a breakthrough discovery that could pave the way for the development of novel non-opioid analgesics to safely and effectively treat neuropathic pain.
  • In November, he launched, as inaugural Director, Monash’s Neuromedicines Discovery Centre, an end-to-end, cross-disciplinary and cross-Faculty Centre to drive novel psychiatric drug discovery, as well as new approaches to neuromedicine-assisted psychotherapies, for the treatment of mental health disorders.

The 2021 QS World University Rankings by Subject ranked Monash University number two in the world for pharmacy and pharmacology.

Ends